Zhongqiang Gao

机构：Buchang Pharma (China), China XD Group (China) · ORCID：0000-0003-4198-8601

发表论文 10 篇 · 总被引 1650 次 · h-index 5

代表论文

• Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions (2020 · Journal of Thoracic Disease · 被引 1505)
• A New Path Planning Method Based on Firefly Algorithm (2012 · 被引 57)
• Analysis of cable failure modes and cable joint failure detection via sheath circulating current (2014 · 被引 36)
• Scalable Motif Counting for Large-scale Temporal Graphs (2022 · 2022 IEEE 38th International Conference on Data Engineering (ICDE) · 被引 23)
• Nurses’ experiences in response to COVID‐19 in a psychiatric ward in Singapore (2021 · International Nursing Review · 被引 23)
• First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects (2022 · Frontiers in Pharmacology · 被引 5)